OakChart

LifeStance Health Group Inc

LFSTHealthcare·Medical Care Facilities·USA·Mid·NASD·Nov 12 • 3:59 PM ET

14.15-0.22 (-1.53%)
2026-11-13 13:25 CET
Market cap
$5.38B
Revenue, TTM
1,676.89 USD m
Net income, TTM
71.91 USD m
Free cash flow, TTM
179.27 USD m
EPS diluted, TTM
0.18
76.69
Compare

Price

LFST against its 20, 50 and 200-day averages
Terms2050200Beat
Patternshover a marker to name it
RS 100Sales 455Price4364397.5010.0012.5015.0014.8M29.5MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26LFSTclose 14.1520-day 13.2950-day 12.77200-day 9.6414.1552w high 15.6652w low 6.0252-week range, not 6 months

9.6% under the 52-week high of 15.66 on 5 Nov 2026. 52-week low 6.02 on 18 Nov 2025. Last 15 sessions, 26.1% high to low

Volume 0.00× normal · the session has not printed · the line is the 50-bar volume average

Setup. RS line 100
CANSLIM 6 of 6
VCP 5 of 6 — fails: RSI (14): Not Overbought (<60)
Minervini 4 of 4
Zanger 2 of 5 — fails: Performance: Week +10%; 20-Day High/Low: 0-5% below High; Relative Volume: Over 1.5
Leaders 5 of 5
Breakout 2 of 4 — fails: 52-Week High/Low: New High; Relative Volume: Over 2
Growth 2 of 4 — fails: EPS Growth Next Year: High (>25%); Return on Equity: Over +15%
Quality 1 of 5 — fails: Return on Equity: Over +15%; Net Profit Margin: High (>20%); Debt/Equity: Low (<0.1); P/E: Under 25
Value 0 of 4 — fails: P/E: Under 15; P/B: Under 2; Return on Equity: Over +15%; Debt/Equity: Low (<0.1)
Income 1 of 4 — fails: Dividend Growth: Growing 2+ Years; P/E: Under 25 — not on the tape: Dividend Yield: Over 2%
Small Cap 3 of 4 — fails: Float: Under 100M
Accumulation 3 of 4 — fails: Institutional Transactions: Over +10%
Relative Strength 3 of 3

Profile

LFST
52-week range, 84% of the way up
6.0215.66

Lifestance Health Group, Inc. provides outpatient mental health services. It offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. The firm operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. The company was founded by Michael K. Lester, Gwen H. Booth and Danish J. Qureshi in 2017 and is headquartered in Scottsdale, AZ.

IndexRUT
Employees10961
IPOJun 10, 2021
Beta1.30
ATR, 14d0.67
Rel volume0.00
Short float5.30%
Insider own32.13%
Inst own66.15%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap$5.38B
Enterprise Value5.64B
Income71.91M
Sales1.68B
Book / share3.93
Cash / share0.58
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees10961
IPOJun 10, 2021

Ratios

Price / earnings76.69
Forward price / earnings57.83
Price / earnings / growth0.32
Price / sales3.21
Price / book3.60
Price / cash24.59
Price / free cash flow30.01
Value / cash profit34.56
Value / sales3.36
Quick Ratio1.44
Current Ratio1.44
Debt / equity0.32
Long-term debt / equity0.28
Options and shortYes / Yes

Earnings

Earnings / share0.18
Earnings next year0.24
Earnings next quarter0.05
Earnings this year893.66%
Earnings next year23.11%
Earnings growth, 5 years182.87%
Past earnings growth- -
Past sales growth18.33% 30.44%
Earnings vs last year886.97%
Sales vs last year22.62%
Earnings vs last quarter1942.86%
Sales vs last quarter25.30%
EarningsNov 05 BMO
Surprise62.60% 5.62%

Ownership

Insiders own32.13%
Insider trades-36.02%
Institutions own66.15%
Institution trades4.24%
Return on assets3.32%
Return on equity4.82%
Return on capital3.77%
Gross Margin31.05%
Operating margin6.39%
Profit Margin4.29%
20-day average6.45%
50-day average10.85%
200-day average46.79%

Technical

Shares out380.19M
Shares floating258.02M
Short / float5.30%
Short ratio2.68
Short interest13.66M
52-week high15.66 -9.6%
52-week low6.02 +135.2%
Volatility6.29% 4.99%
Average range0.67
Strength index61.28
Market sensitivity1.30
Relative volume0.00
Avg Volume5.09M
Volume0

Performance

Perf Week5.36%
Perf Month13.02%
Perf Quarter13.93%
Perf Half Y79.34%
Perf YTD100.99%
Perf Year119.72%
Perf 3Y152.23%
Perf 5Y36.85%
Perf 10Y-
Recommendation1.45
Target Price16.80
Prev Close14.15
Price14.15
Change %0.00%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
Jun 05, 2026InitiatedGoldmanNeutral$9-36.4%
Dec 09, 2025InitiatedBarclaysOverweight$8-43.5%
Nov 13, 2025InitiatedBMO Capital MarketsOutperform$8-43.5%
Jul 25, 2025InitiatedBTIG ResearchBuy$8-43.5%
May 27, 2025UpgradeUBSNeutral → Buy$8.50-39.9%
Apr 08, 2025InitiatedKeyBanc Capital MarketsOverweight$9-36.4%
Apr 03, 2025InitiatedCanaccord GenuityBuy$8-43.5%
Dec 16, 2024UpgradeGoldmanNeutral → Buy$10-29.3%
Jan 03, 2024InitiatedBarclaysUnderweight$7-50.5%
May 15, 2023DowngradeTD CowenOutperform → Market Perform$8 → $9-36.4%

Peers

Mkt cap
TickerCompanyMkt cap
ACHCAcadia Healthcare Company Inc3.52B
UHSUniversal Health Services Inc11.15B
CONConcentra Group Holdings Parent Inc5.44B
USPHU.S. Physical Therapy Inc1.47B
TDOCTeladoc Health Inc1.60B
MDPediatrix Medical Group Inc2.45B
PRVAPrivia Health Group Inc3.02B
ASTHAstrana Health Inc1.57B
CMPSCompass Pathways Plc ADR1.31B
HIMSHims & Hers Health Inc4.64B

Insider trading

latest 14 of 60
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Miller Lisa KChief Operating OfficerNov 11 '26Sale14.6814,663215,253251,904Nov 12 05:00 PM
Burdick Kenneth ADirectorNov 10 '26Option Exercise7.6175,000570,7502,979,221Nov 12 05:00 PM
Burdick Kenneth ADirectorNov 10 '26Sale14.6075,0001,095,0002,904,221Nov 12 05:00 PM
Burdick Kenneth ADirectorNov 09 '26Sale14.4166,589959,5472,904,221Nov 12 05:00 PM
Burdick Kenneth ADirectorNov 12 '26Proposed Sale14.31159,6242,284,845Nov 12 04:19 PM
Miller Lisa KOfficerNov 11 '26Proposed Sale14.6814,663215,253Nov 12 07:18 AM
Burdick Kenneth ADirectorNov 10 '26Proposed Sale14.6075,0001,095,082Nov 10 12:04 PM
KIMBERLY PARDOINVESTORNov 10 '26Proposed Sale14.402,216,58531,918,824Nov 10 11:46 AM
RYAN PARDOOFFICERNov 10 '26Proposed Sale14.40587,9208,466,048Nov 10 09:45 AM
Burdick Kenneth ADirectorNov 09 '26Proposed Sale14.4166,589959,716Nov 09 02:47 PM
TPG GP A, LLC10% OwnerSep 11 '26Sale12.2918,409,705226,255,27479,691,702Sep 15 04:16 PM
Paunovich VukasinChief Technology OfficerSep 02 '26Sale12.8742,067541,402205,379Sep 04 04:51 PM
Paunovich VukasinOfficerSep 02 '26Proposed Sale12.8742,067541,245Sep 02 01:52 PM
DeLuca TeresaDirectorAug 14 '26Sale12.687,50095,10097,093Aug 18 05:13 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 107.13B
IWMiShares Russell 2000 Index FundAUM: 77.86B
VTIVanguard Morningstar Total Stock Market ETFAUM: 696.31B
VBVanguard Morningstar Small-Cap ETFAUM: 80.23B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.19B
IWOiShares Russell 2000 Growth ETFAUM: 14.25B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.64B
VBKVanguard Morningstar Small-Cap Growth ETFAUM: 22.68B
VXFVanguard Extended Market Index ETFAUM: 30.79B
XSMOInvesco S&P SmallCap Momentum ETFAUM: 2.78B

News

latest 14 of 200

Quarterly earnings

2026Q3 EPS 0.060 beat 0.037, from 0.000 a year earlier. Sales 455.86 beat 431.59, from 363.8 a year earlier
EPS
0.0600-0.0372024Q4 EPS -0.010 against -0.03724Q42025Q1 EPS 0.000 against -0.03125Q12025Q2 EPS -0.010 against -0.02425Q22025Q3 EPS 0.000 against -0.00825Q32025Q4 EPS 0.010 against -0.00125Q42026Q1 EPS 0.040 against 0.00726Q12026Q2 EPS 0.060 against 0.03326Q22026Q3 EPS 0.060 against 0.03726Q3
Sales, USD millions
455.8602024Q4 sales 325.5 against 313.9824Q42025Q1 sales 332.97 against 332.9125Q12025Q2 sales 345.31 against 345.2525Q22025Q3 sales 363.8 against 356.8725Q32025Q4 sales 382.2 against 378.4225Q42026Q1 sales 403.5 against 387.4626Q12026Q2 sales 435.35 against 414.5826Q22026Q3 sales 455.86 against 431.5926Q3

The outline behind the bar is the estimate. The filled bar is the print. Green beat it, red missed it.

PeriodReportedEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mSurpriseYear-ago quarterAnalystsNext session
2026Q3ended 2026-09-302026-11-05 08:300.0600.0370.059455.86431.59EPS +62.6% · sales +5.6%vs 2025Q3, year-ago quarter · EPS - · sales +25.3%7 EPS · 9 salesOpen +3.80% vs SPY -0.17%. Close -5.49% vs SPY -4.41%
2026Q2ended 2026-06-302026-08-06 08:300.0600.0330.061435.35414.58EPS +82.9% · sales +5.0%vs 2025Q2, year-ago quarter · EPS -700.0% · sales +26.1%6 EPS · 9 salesOpen +5.98% vs SPY +0.05%. Close +2.80% vs SPY -0.16%
2026Q1ended 2026-03-312026-05-07 08:300.0400.0070.036403.5387.46EPS +455.6% · sales +4.1%vs 2025Q1, year-ago quarter · EPS - · sales +21.2%6 EPS · 8 salesOpen +8.70% vs SPY +0.17%. Close +20.24% vs SPY -0.31%
2025Q4ended 2025-12-312026-02-25 08:300.010-0.0010.030382.2378.42EPS -1211.1% · sales +1.0%vs 2024Q4, year-ago quarter · EPS -200.0% · sales +17.4%6 EPS · 8 salesOpen +11.83% vs SPY +0.41%. Close +3.78% vs SPY +0.84%
2025Q3ended 2025-09-302025-11-06 08:300.000-0.0080.003363.8356.87EPS -100.0% · sales +1.9%vs 2024Q3, year-ago quarter · EPS -100.0% · sales +16.3%6 EPS · 7 salesOpen +11.02% vs SPY -0.16%. Close +29.94% vs SPY -1.07%
2025Q2ended 2025-06-302025-08-07 08:30-0.010-0.024-0.010345.31345.25EPS -58.8% · sales +0.0%vs 2024Q2, year-ago quarter · EPS -83.3% · sales +10.6%7 EPS · 8 salesOpen +3.59% vs SPY +0.55%. Close -1.03% vs SPY -0.08%
2025Q1ended 2025-03-312025-05-07 08:300.000-0.0310.002332.97332.91EPS -100.0% · sales +0.0%vs 2024Q1, year-ago quarter · EPS -100.0% · sales +10.8%7Open -6.26% vs SPY +0.24%. Close -15.88% vs SPY +0.42%
2024Q4ended 2024-12-312025-02-27 08:30-0.010-0.037-0.019325.5313.98EPS -73.0% · sales +3.7%vs 2023Q4, year-ago quarter · EPS -91.7% · sales +16.0%5Open +6.79% vs SPY +0.39%. Close +3.06% vs SPY -1.60%
2024Q3ended 2024-09-302024-11-07 08:30-0.020-0.068-0.016312.7302.25EPS -70.5% · sales +3.5%vs 2023Q3, year-ago quarter · EPS -88.2% · sales +18.9%6 EPS · 5 salesOpen +8.70% vs SPY +0.35%. Close +7.71% vs SPY +0.77%
2024Q2ended 2024-06-302024-08-08 08:30-0.060-0.065-0.061312.33305.85EPS -8.0% · sales +2.1%vs 2023Q2, year-ago quarter · EPS -53.8% · sales +20.3%5Open +3.81% vs SPY +1.01%. Close +7.62% vs SPY +2.31%
2024Q1ended 2024-03-312024-05-09 08:30-0.060-0.079-0.056300.44299.02EPS -24.4% · sales +0.5%vs 2023Q1, year-ago quarter · EPS -33.3% · sales +18.9%6 EPS · 5 salesOpen +3.87% vs SPY +0.04%. Close +2.01% vs SPY +0.58%
2023Q4ended 2023-12-312024-02-28 08:30-0.120-0.087-0.119280.6262.9EPS +38.4% · sales +6.7%vs 2022Q4, year-ago quarter · EPS -7.7% · sales +22.3%7 EPS · 6 salesOpen +20.30% vs SPY -0.32%. Close +30.00% vs SPY -0.13%
2023Q3ended 2023-09-302023-11-08 08:30-0.170-0.068-0.165262.9255.18EPS +148.9% · sales +3.0%vs 2022Q3, year-ago quarter · EPS +54.5% · sales +20.8%6-
2023Q2ended 2023-06-302023-08-09 08:30-0.130-0.076-0.125259.58255.19EPS +71.3% · sales +1.7%vs 2022Q2, year-ago quarter · EPS -31.6% · sales +23.9%6-
2023Q1ended 2023-03-312023-05-10 08:30-0.090-0.092-0.095252.59246.69EPS -2.2% · sales +2.4%vs 2022Q1, year-ago quarter · EPS -50.0% · sales +24.4%5-
2022Q4ended 2022-12-312023-03-08 08:30-0.130-0.128-0.124229.4216.19EPS +1.6% · sales +6.1%vs 2021Q4, year-ago quarter · EPS -63.2% · sales +20.7%5-

Annual earnings

2025FY EPS 0.020 beat -0.004, from -0.150 a year earlier. Sales 1,424 beat 1,420, from 1,251 a year earlier
EPS
0.0200-1.0502021FY EPS -1.050 against -0.87020212022FY EPS -0.610 against -0.60620222023FY EPS -0.510 against -0.48420232024FY EPS -0.150 against -0.17420242025FY EPS 0.020 against -0.0042025
Sales, USD millions
1,42402021FY sales 667.51 against 668.4720212022FY sales 859.5 against 846.4220222023FY sales 1,056 against 1,03820232024FY sales 1,251 against 1,23920242025FY sales 1,424 against 1,4202025

Reported years only. The outline behind the bar is the estimate. A later year with no print stays in the table.

earnings feed, not the snapshot. Not the statement ratio.

PeriodEPS adjustedEPS estEPS reportedSales act, USD mSales est, USD mP/E, earnings feed
2028FYestimate-0.453--2,28531.26
2027FYestimate-0.245--1,98557.83
2026FYestimate-0.199--1,74771.21
2025FY0.020-0.0040.0221,4241,420352.00
2024FY-0.150-0.174-0.1521,2511,239-
2023FY-0.510-0.484-0.5071,0561,038-
2022FY-0.610-0.606-0.607859.5846.42-
2021FY-1.050-0.870-1.050667.51668.47-

Quarterly results

2026Q3 revenue 455.86, from 363.81 a year earlier. Operating margin 7.6%, from 2.2% a year earlier
Revenue, USD millions
455.8602024Q4 revenue 325.4824Q42025Q1 revenue 332.9725Q12025Q2 revenue 345.3125Q22025Q3 revenue 363.8125Q32025Q4 revenue 382.1925Q42026Q1 revenue 403.4826Q12026Q2 revenue 435.3526Q22026Q3 revenue 455.8626Q3
Operating margin
7.60-0.72024Q4 operating margin 0.3%24Q42025Q1 operating margin 0.5%25Q12025Q2 operating margin -0.7%25Q22025Q3 operating margin 2.2%25Q32025Q4 operating margin 4.8%25Q42026Q1 operating margin 5.5%26Q12026Q2 operating margin 7.2%26Q22026Q3 operating margin 7.6%26Q3

From the quarterly statement. Not an estimate.

Estimate revisions

Latest snapshot of each period and type. 2026FY E 0.20 per share.
PeriodTypeScaleDateMeanvs prior date
2026FYEper share2026-11-110.20+3.4%
2026Q4Eper share2026-11-110.05+3.7%
2026FYRper share2026-11-110.20+5.2%
2026Q4Rper share2026-11-110.05+5.5%
2026FYSUSD millions2026-11-111,747+0.3%
2026Q4S-2026-11-11454.66+0.4%
2026Q3Eper share2026-11-020.040.0%
2026Q3S-2026-11-02431.590.0%
2026Q3Rper share2026-10-270.040.0%
2026Q2S-2026-07-30414.580.0%
2026Q2Eper share2026-07-270.030.0%
2026Q2Rper share2026-07-270.040.0%
2026Q1S-2026-04-22387.46+0.0%
2026Q1Eper share2026-02-270.01+5.9%
2026Q1Rper share2026-02-270.01+7.1%
2025FYEper share2026-02-250.00-139.5%
2025Q4Eper share2026-02-250.00-477.8%
2025FYRper share2026-02-250.00-100.0%
2025Q4Rper share2026-02-250.00-100.0%
2025FYSUSD millions2026-02-251,4200.0%
2025Q4S-2026-02-25377.71-0.2%
2025Q3Eper share2025-10-25-0.010.0%
2025Q3Rper share2025-10-25-0.010.0%
2025Q3S-2025-10-25355.610.0%
2025Q2Eper share2025-07-31-0.02-5.4%
2025Q2S-2025-07-31345.25+0.1%
2025Q2Rper share2025-05-26-0.04-17.8%
2025Q1Eper share2025-05-02-0.03+0.4%
2025Q1S-2025-05-02332.910.0%
2025Q1Rper share2025-04-02-0.04-5.1%
2024FYEper share2025-02-27-0.17-0.6%
2024Q4Eper share2025-02-27-0.04+3.5%
2024FYRper share2025-02-27-0.18-4.3%
2024Q4Rper share2025-02-27-0.04-15.1%
2024FYSUSD millions2025-02-271,2390.0%
2024Q4S-2025-02-27313.74-0.1%
2024Q3Eper share2024-11-04-0.070.0%
2024Q3Rper share2024-11-04-0.070.0%
2024Q3S-2024-10-28302.250.0%
2024Q2Eper share2024-07-23-0.070.0%
2024Q2Rper share2024-07-23-0.060.0%
2024Q2S-2024-07-23305.850.0%
2024Q1Eper share2024-03-12-0.08-0.8%
2024Q1Rper share2024-03-12-0.08-2.2%
2024Q1S-2024-03-12299.02+0.0%
2023FYEper share2024-02-03-0.480.0%
2023FYRper share2024-01-30-0.470.0%
2023FYSUSD millions2024-01-231,0380.0%

Estimate history

Annual
Metric2019202020212022202320242025TTMMRQ
EPS per share-0.158-0.833-1.05-0.607-0.507-0.1520.0250.1845-
Sales USD millions2133776688601,0561,2511,4241,677-
Shares million shares374374374376379383388-380
Quarterly
MetricQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
EPS per share-0.016-0.0190.002-0.010.0030.030.0360.0610.057
Sales USD millions313325333345364382403435456
Shares million shares383383389389389388388382380

Income statement, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/2019
Total Revenue1,676.891,424.29+13.9%1,250.97+18.5%1,055.66+22.8%859.54+28.8%667.51+77.0%377.22+77.5%212.52
Cost of Goods Sold Incl. D&A1,156.161,017.94+10.7%919.52+10.3%834.01+20.6%691.72+33.0%520.14--
Gross Profit520.73406.35+22.6%331.45+49.5%221.66+32.1%167.82+13.9%147.37--
Selling, General and Administrative Excl. Other413.57380.64+5.2%361.91-11.5%409.01+9.4%373.90-13.2%430.54+30.2%330.74+73.0%191.18
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income107.1625.71-30.46-187.35-206.08-283.17-1934.0%15.44+1.3%15.24
Interest Expense9.7911.66-56.1%26.54+25.1%21.22+140.3%8.83-64.0%24.51+10.8%22.13+309.1%5.41
Unusual Expense6.362.71+46.5%1.85-96.2%48.94+165.3%18.45-23.0%23.96-36.0%37.44+1810.2%1.96
Net Income Before Taxes89.8212.36-57.61-206.58-232.73-333.11-44.41-663.6%7.88
Income Taxes17.912.70-0.17-20.32-17.17-25.91-6.34-386.9%2.21
Consolidated Net Income71.919.66-57.44-186.26-215.56-307.20-38.07-771.4%5.67
Net Income From Continuing Operations71.919.66-57.44-186.26-215.56-307.20-38.07-771.4%5.67
Net Income71.919.66-57.44-186.26-215.56-343.95-311.31-58.90
EPS (Recurring) per share0.200.03-0.15-0.41-0.57-1.00-0.76-0.15
EPS (Basic, Before Extraordinaries) per share0.190.03-0.15-0.51-0.61-1.05-0.83-0.16
EPS (Diluted) per share0.180.02-0.15-0.51-0.61-1.05-0.83-0.16
EBITDA163.1080.46+98.7%40.49-106.91-136.88-229.03-592.7%46.48+117.8%21.34
Non-Operating Income (Expense)-1.191.03-16.3%1.23-97.6%50.92+7982.5%0.63-1.47-0.280.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense55.1659.01-1.9%60.18-23.4%78.52-47.0%148.07-21.8%189.39+17767.0%1.06+2550.0%0.04
Price To Earnings Ratio ratio statement ratio, not the snapshot76.6976.69------
Price To Sales Ratio ratio2.811.932.232.732.044.67--
Gross Margin %31.0528.5326.5021.0019.5222.08--
Operating Margin %6.391.80-2.43-17.75-23.98-42.424.097.17
Net Margin %4.290.68-4.59-17.64-25.08-51.53-82.53-27.72
Shares Outstanding million shares380.19388.32+1.5%382.74+1.1%378.73+0.7%375.96+0.5%374.25+0.2%373.650.0%373.65
Market Capitalization5,379.705,379.70+90.8%2,820.06-4.9%2,964.49+59.6%1,857.37-47.9%3,561.90-0.8%3,591.83-

Income statement, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Total Revenue455.86+25.3%435.35+26.1%403.48+21.2%382.19+17.4%363.81+16.3%345.31+10.6%332.97+10.8%325.48+16.0%
Cost of Goods Sold Incl. D&A309.40+18.6%296.56+18.2%280.86+18.5%269.33+16.7%260.78+14.7%250.89+7.6%236.94+3.8%230.72+5.1%
Gross Profit146.47+42.2%138.79+47.0%122.61+27.7%112.86+19.1%103.03+20.8%94.42+19.2%96.03+33.1%94.77+55.1%
Selling, General and Administrative Excl. Other111.67+17.5%107.24+10.8%100.24+6.4%94.41+0.7%95.04+11.6%96.79+2.1%94.20+6.0%93.77+1.5%
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income34.79+336.0%31.5522.37+1122.4%18.45+1745.0%7.98+4333.3%-2.361.831.00
Interest Expense2.49-11.4%2.63-9.3%1.79-41.7%2.88-69.4%2.81-48.1%2.90-50.2%3.07-48.0%9.40+70.0%
Unusual Expense4.60+820.0%1.44-6.5%-0.11-125.6%0.43-41.1%0.50+35.1%1.54+1.3%0.430.73-77.3%
Net Income Before Taxes27.40+499.6%27.4619.7615.204.57-5.94-1.47-8.88
Income Taxes5.02+43.4%3.855.523.543.50+514.0%-2.15-425.8%-2.18-705.6%-1.76-126.5%
Consolidated Net Income22.39+1973.1%23.6114.24+1905.6%11.671.08-3.790.71-7.11
Net Income From Continuing Operations22.39+1973.1%23.6114.24+1905.6%11.671.08-3.790.71-7.11
Net Income22.39+1973.1%23.6114.24+1905.6%11.671.08-3.790.71-7.11
EPS (Recurring) per share0.070.060.040.030.00-0.010.00-0.02
EPS (Basic, Before Extraordinaries) per share0.060.060.040.030.00-0.010.00-0.02
EPS (Diluted) per share0.060.060.040.030.00-0.010.00-0.02
EBITDA49.73+130.9%45.80+293.5%35.69+128.9%31.88+103.4%21.54+40.8%11.64+284.2%15.59+164.7%15.67
Non-Operating Income (Expense)-0.30-0.02-102.3%-0.92-560.0%0.06-76.9%-0.09-140.9%0.86+196.6%0.20-56.5%0.26-85.0%
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense14.35-0.7%15.60-6.5%12.01-18.2%13.20+3.4%14.45+22.8%16.68-14.0%14.68-9.7%12.76-22.8%
Price To Earnings Ratio ratio statement ratio, not the snapshot76.69180.91254.80-----
Price To Sales Ratio ratio2.812.621.681.921.561.522.032.25
Gross Margin %32.1331.8830.3929.5328.3227.3428.8429.12
Operating Margin %7.637.255.544.832.19-0.680.550.31
Net Margin %4.915.423.533.050.30-1.100.21-2.19
Shares Outstanding million shares380.19-2.3%382.02-1.8%387.81-0.3%388.32+1.5%389.00+1.7%389.08+1.5%388.83+1.8%382.74+1.1%
Market Capitalization5,379.70+151.5%4,153.70+106.6%2,482.92-3.1%2,738.56-2.9%2,139.15-20.1%2,010.49+7.1%2,561.10+9.0%2,820.06-4.9%

Balance sheet, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/2019
Cash & Short Term Investments248.64+60.9%154.57+96.1%78.82-27.4%108.62-26.6%148.03+686.1%18.83+441.1%3.48
Short Term Receivables99.50-24.6%132.03+5.1%125.64+18.4%106.15+6.9%99.31+92.8%51.52+145.0%21.03
Inventories0.000.000.000.000.000.000.00
Other Current Assets68.06+162.7%25.91+21.8%21.27+15.3%18.45-3.8%19.18+223.4%5.93+103.8%2.91
Total Current Assets416.20+33.2%312.51+38.4%225.73-3.2%233.22-12.5%266.52+249.4%76.28+178.1%27.43
Net Property, Plant & Equipment311.30-0.8%313.92-12.5%358.93-8.8%393.62+158.6%152.24+156.5%59.35+164.6%22.43
Total Investments and Advances0.000.000.000.000.000.000.00
Intangible Assets1,471.01-0.9%1,484.14-2.0%1,514.42-1.4%1,536.23+2.1%1,504.90+5.1%1,431.45+523.6%229.56
Deferred Tax Assets112.59+3.5%108.74-11.8%123.24+5.3%117.05+175.0%42.56+292.3%10.85+402.3%2.16
Other Assets5.42-29.8%7.72-29.1%10.89+0.9%10.79+212.8%3.45+30.2%2.65+94.9%1.36
Total Assets2,316.53+4.0%2,227.04-0.3%2,233.21-2.5%2,290.92+16.3%1,969.66+24.6%1,580.58+458.6%282.94
Short Term Debt Incl. Current Port. of LT Debt60.04+5.9%56.70+14.8%49.40+20.0%41.17+3018.9%1.32-64.7%3.74+345.2%0.84
Accounts Payable6.12-15.5%7.24+2.7%7.05-42.6%12.29-13.1%14.15+84.0%7.69+111.3%3.64
Income Tax Payable-----0.45+136.8%0.19
Other Current Liabilities185.80+12.6%164.94+12.6%146.42+19.5%122.55+21.0%101.28+58.1%64.05+27.3%50.33
Total Current Liabilities251.96+10.1%228.89+12.8%202.87+15.3%176.00+50.7%116.75+53.8%75.92+38.0%55.01
Long Term Debt414.48-3.3%428.49-7.2%461.64+5.5%437.67+178.0%157.42-56.6%362.53+357.1%79.31
Provision for Risks Charges0.000.000.000.000.000.000.00
Deferred Tax Liabilities129.00+4.8%123.07-11.3%138.81-10.9%155.75+60.8%96.84+5.2%92.08+2949.0%3.02
Other Liabilities0.07-77.4%0.31-67.4%0.95-65.8%2.78-94.8%53.63+211.6%17.21+90.4%9.04
Total Liabilities795.51+1.9%780.75-2.9%804.28+4.2%772.19+81.8%424.64-22.5%547.74+274.2%146.38
Non-Equity Reserves0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.00-100.0%35.00-88.4%302.91
Common Equity1,521.02+5.2%1,446.29+1.2%1,428.93-5.9%1,518.72-1.7%1,545.03+54.8%997.84-166.35
Total Shareholders Equity1,521.02+5.2%1,446.29+1.2%1,428.93-5.9%1,518.72-1.7%1,545.03+49.6%1,032.84+656.3%136.56
Accumulated Minority Interest0.000.000.000.000.000.000.00
Total Equity1,521.02+5.2%1,446.29+1.2%1,428.93-5.9%1,518.72-1.7%1,545.03+49.6%1,032.84+656.3%136.56
Total Liabilities & Stockholders Equity2,316.53+4.0%2,227.04-0.3%2,233.21-2.5%2,290.92+16.3%1,969.66+24.6%1,580.58+458.6%282.94
Book Value Per Share per share3.92+3.7%3.78+0.3%3.77-6.7%4.04-2.2%4.13+54.7%2.67-0.45
Tangible Book Value Per Share per share0.13-0.10-0.23-0.05-145.5%0.11-1.16-1.06
Full-Time Employees people10,961+7.3%10,218+9.6%9,325+19.1%7,830+18.0%6,635+49.1%4,4500.0%4,450
Price to Book Ratio ratio3.601.962.041.212.312.33-
Return on Assets %0.43-2.58-8.23-10.12-17.31-4.09-
Return on Equity %0.65-4.00-12.64-14.07-23.83-6.51-
Return on Invested Capital %0.50-3.06-9.85-11.02-18.04-2.732.63
Quick Ratio ratio1.651.371.111.332.281.000.50
Current Ratio ratio1.651.371.111.332.281.000.50

Cash flow, annual

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
MetricTTM2025FY12/31/20252024FY12/31/20242023FY12/31/20232022FY12/31/20222021FY12/31/20212020FY12/31/20202019FY12/31/2019
Net Income71.919.66-57.44-186.26-215.56-307.20-38.07-771.4%5.67
Depreciation55.9454.75-22.8%70.95-11.8%80.44+16.2%69.20+27.8%54.14+74.4%31.05+409.9%6.09
Other Funds (Non Cash)119.12119.66-2.0%122.08-15.6%144.58-37.9%232.83-19.0%287.29+4896.3%5.75+984.9%0.53
Funds from Operations249.38186.50+38.5%134.63+699.5%16.84-75.8%69.73+857.8%7.28-7.78-155.3%14.06
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-21.79-40.34-27.37-33.72-16.94-891.6%2.14-0.75-125.1%2.99
Cash from Operating Activities227.60146.15+36.3%107.26-16.88-132.0%52.79+460.4%9.42-8.53-150.0%17.05
Capital Expenditures-48.33-36.12-21.57-40.52-79.25-94.49-38.07-14.31
Net Assets From Acquisitions-9.590.000.00-19.82-60.21-99.58-823.10-59.06
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-57.92-36.12-21.57-60.34-139.46-194.08-861.17-73.38
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock-117.060.000.000.000.00-100.0%549.90+2649.5%20.000.00
Repurchase of Common Pref Stock-122.430.000.000.000.000.00-1.000.00
Sale of Common Pref Stock5.370.000.000.000.00-100.0%549.90+2518.6%21.000.00
Proceedsfrom Stock Options0.000.000.000.000.00-100.0%549.90+2518.6%21.000.00
Issuance or Reduction of Debt, Net-12.69-7.25-3.50-106.4%55.09-9.2%60.68-223.77-179.3%282.07+427.3%53.49
Change in Long Term Debt-12.69-7.25-3.50-106.4%55.09-9.2%60.68-223.77-179.3%282.07+427.3%53.49
Issuance of Long Term Debt0.000.00-100.0%285.99+396.9%57.56-77.0%250.06+159.3%96.44-78.9%457.08+746.9%53.97
Reduction of Long Term Debt-12.69-7.25-289.49-2.47-189.38-320.21-175.01-0.49
Net Financing Active Other Cash Flow-25.02-8.71-6.44-7.67-13.42-12.28-102.0%610.20-5.02
Other Financing Activities Uses-25.02-8.71-6.44-7.67-13.42-12.28-23.38-5.02
Cash from Financing Activities-154.77-15.96-9.95-121.0%47.43+0.4%47.26-84.9%313.86-65.6%912.27+1782.5%48.46
Net Change in Cash14.9194.07+24.2%75.75-29.80-39.41-130.5%129.20+203.5%42.57-7.86
Free Cash Flow179.27110.03+28.4%85.69-57.40-26.47-85.07-46.60-1807.0%2.73
Preferred Dividends (Cash Flow)-0.000.000.000.00---
Price to Free Cash Flow ratio26.2525.0332.61-----
Deferred Taxes & Investment Tax Credit-2.42-0.96-21.92-16.73-26.95-6.50-469.3%1.76

Balance sheet, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Cash & Short Term Investments218.82+7.3%225.94+19.6%194.80+45.0%248.64+60.9%203.90+98.7%188.93+117.2%134.34+171.7%154.57+96.1%
Short Term Receivables120.94-0.1%110.96-14.3%122.92-12.4%99.50-24.6%121.07-23.5%129.48-22.6%140.37-20.2%132.03+5.1%
Inventories0.000.000.000.000.000.000.000.00
Other Current Assets37.02+4.6%41.06+1.5%38.20+27.6%68.06+162.7%35.40+34.9%40.44+71.6%29.93+59.8%25.91+21.8%
Total Current Assets376.78+4.6%377.97+5.3%355.91+16.8%416.20+33.2%360.38+25.6%358.85+29.2%304.63+24.8%312.51+38.4%
Net Property, Plant & Equipment328.82+6.6%321.70+5.9%312.99+0.4%311.30-0.8%308.38-5.1%303.76-9.6%311.79-10.5%313.92-12.5%
Total Investments and Advances0.000.000.000.000.000.00-100.0%0.000.00
Intangible Assets1,475.43+0.1%1,477.36+0.0%1,472.14-0.6%1,471.01-0.9%1,474.10-1.0%1,477.31-1.1%1,480.68-1.4%1,484.14-2.0%
Deferred Tax Assets---112.59+3.5%---108.74-11.8%
Other Assets5.25-14.2%4.47-35.0%4.84-36.1%5.42-29.8%6.12-17.4%6.88-18.7%7.57-37.2%7.72-29.1%
Total Assets2,186.28+1.7%2,181.50+1.6%2,145.88+2.0%2,316.53+4.0%2,148.97+1.9%2,146.80+1.3%2,104.67-0.1%2,227.04-0.3%
Short Term Debt Incl. Current Port. of LT Debt59.54-0.9%61.00+5.2%65.49+16.2%60.04+5.9%60.06+15.8%57.96+11.2%56.36+7.0%56.70+14.8%
Accounts Payable5.50-55.0%11.05+41.8%4.29-42.2%6.12-15.5%12.21+67.7%7.79-21.9%7.42-37.9%7.24+2.7%
Other Current Liabilities196.09+25.5%202.70+14.8%169.95+18.3%185.80+12.6%156.28-1.3%176.53+6.6%143.61+0.5%164.94+12.6%
Total Current Liabilities261.13+14.3%274.75+13.4%239.73+15.6%251.96+10.1%228.56+5.1%242.28+6.4%207.380.0%228.89+12.8%
Long Term Debt415.98+0.6%413.15-0.8%411.28-3.4%414.48-3.3%413.58-5.5%416.29-6.5%425.71-6.0%428.49-7.2%
Provision for Risks Charges0.000.000.000.000.000.000.000.00
Deferred Tax Liabilities16.41+17.3%16.41+16.1%16.41+15.4%129.00+4.8%13.99-8.1%14.13-11.0%14.22-11.0%123.07-11.3%
Other Liabilities0.37+270.0%0.04-77.8%1.05+320.0%0.07-77.4%0.10-73.7%0.18-68.4%0.25-67.1%0.31-67.4%
Total Liabilities693.89+5.7%704.35+4.7%668.47+3.2%795.51+1.9%656.23-2.2%672.88-2.4%647.57-4.4%780.75-2.9%
Non-Equity Reserves0.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.00
Common Equity1,492.390.0%1,477.15+0.2%1,477.42+1.4%1,521.02+5.2%1,492.74+3.9%1,473.92+3.1%1,457.10+2.0%1,446.29+1.2%
Total Shareholders Equity1,492.390.0%1,477.15+0.2%1,477.42+1.4%1,521.02+5.2%1,492.74+3.9%1,473.92+3.1%1,457.10+2.0%1,446.29+1.2%
Accumulated Minority Interest0.000.000.000.000.000.000.000.00
Total Equity1,492.390.0%1,477.15+0.2%1,477.42+1.4%1,521.02+5.2%1,492.74+3.9%1,473.92+3.1%1,457.10+2.0%1,446.29+1.2%
Total Liabilities & Stockholders Equity2,186.28+1.7%2,181.50+1.6%2,145.88+2.0%2,316.53+4.0%2,148.97+1.9%2,146.80+1.3%2,104.67-0.1%2,227.04-0.3%
Book Value Per Share per share3.93+2.3%3.87+2.1%3.81+1.6%3.92+3.7%3.84+2.1%3.79+1.6%3.75+0.3%3.78+0.3%
Tangible Book Value Per Share per share0.04-20.0%-0.000.010.130.05-0.01-0.06-0.10
Full-Time Employees people---10,961+7.3%---10,218+9.6%
Price to Book Ratio ratio3.602.811.631.831.451.381.761.96
Return on Assets %3.322.341.090.43-0.43-0.76-1.69-2.58
Return on Equity %4.823.431.580.65-0.62-1.11-2.47-4.00
Return on Invested Capital %1.171.250.750.600.06-0.200.04-0.38
Quick Ratio ratio1.441.381.481.651.581.481.471.37
Current Ratio ratio1.441.381.481.651.581.481.471.37

Cash flow, quarterly

USD millions, except where the row names a unit. The percent under a figure is against the same period a year earlier. TTM has no earlier TTM to compare with, and a ratio or a margin has no change.
Metric2026Q39/30/20262026Q26/30/20262026Q13/31/20262025Q412/31/20252025Q39/30/20252025Q26/30/20252025Q13/31/20252024Q412/31/2024
Net Income22.39+1973.1%23.6114.24+1905.6%11.671.08-3.790.71-7.11
Depreciation14.94+10.2%14.25+1.7%13.32-3.2%13.43-8.5%13.56-10.3%14.01-24.7%13.76-39.0%14.67-34.0%
Other Funds (Non Cash)32.53+9.0%32.10-0.3%26.30-10.6%28.19-12.8%29.84+14.5%32.20-8.1%29.42+2.8%32.33-3.9%
Funds from Operations69.85+57.1%69.96+64.9%53.86+22.7%55.72+43.1%44.47+26.3%42.42+39.6%43.89+45.8%38.94
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-32.8329.95+36.3%-20.751.84-92.1%-17.1821.98+60.6%-46.9823.38-16.0%
Cash from Operating Activities37.02+35.7%99.91+55.1%33.1157.56-7.6%27.29+20.1%64.40+46.2%-3.0962.32+271.0%
Capital Expenditures-14.65-11.99-10.77-10.91-10.29-7.75-7.17-6.30
Net Assets From Acquisitions-0.55-5.89-3.140.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments0.000.000.000.000.000.000.000.00
Purchase of Investments0.000.000.000.000.000.000.000.00
Sale Or Maturity of Investments0.000.000.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-15.21-17.89-13.91-10.91-10.29-7.75-7.17-6.30
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.000.000.00
Change in Capital Stock-24.80-43.15-49.110.000.000.000.000.00
Repurchase of Common Pref Stock-24.80-48.52-49.110.000.000.000.000.00
Sale of Common Pref Stock0.005.370.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-3.62-7.250.00-1.81-1.81-1.81-1.81-1.31-104.1%
Change in Long Term Debt-3.62-7.250.00-1.81-1.81-1.81-1.81-1.31-104.1%
Issuance of Long Term Debt0.000.000.000.00-100.0%0.000.000.00285.99+773.3%
Reduction of Long Term Debt-3.62-7.250.00-1.81-1.81-1.81-1.81-287.30
Net Financing Active Other Cash Flow-0.51-0.48-23.94-0.10-0.21-0.24-8.16-2.75
Other Financing Activities Uses-0.51-0.48-23.94-0.10-0.21-0.24-8.16-2.75
Cash from Financing Activities-28.93-50.88-73.04-1.91-2.02-2.05-9.97-4.06-113.2%
Net Change in Cash-7.12-147.6%31.15-42.9%-53.8444.74-13.9%14.97-4.3%54.59+45.5%-20.2351.96+43.5%
Free Cash Flow22.36+31.5%87.92+55.2%22.3446.65-16.7%17.00-3.8%56.64+45.4%-10.2656.02+941.3%
Price to Free Cash Flow ratio26.2523.8517.6524.8517.9216.6525.4132.92

Revenue breakdown

USD millions, so a column adds up to the income statement. Share is of the latest year in that split. The change is versus the older year shown, not TTM.

Product
Name20242025vs 20242025 share
Services-Health Services1,250.971,424.29+13.9%100.0%
Total1,250.971,424.29+13.9%100.0%
Region
Name20242025vs 20242025 share
United States1,250.971,424.29+13.9%100.0%
Total1,250.971,424.29+13.9%100.0%

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.30%13.7M258.0M4.37M
2026-10-155.31%13.8M259.4M4.31M
2026-09-305.94%15.5M261.2M4.43M
2026-09-156.23%16.3M261.2M4.22M
2026-08-315.59%13.6M243.5M3.74M
2026-08-144.69%11.4M243.7M3.71M
2026-07-314.16%9.6M230.1M4.16M
2026-07-154.05%9.5M233.6M4.75M
2026-06-304.09%9.6M235.1M4.38M
2026-06-153.43%8.0M234.2M3.90M
2026-05-293.39%7.9M234.4M3.98M
2026-05-153.66%8.6M234.4M4.05M
2026-04-303.76%6.9M183.4M2.97M
2026-04-153.56%6.6M184.3M2.19M
2026-03-314.49%7.2M160.6M2.22M
2026-03-134.86%7.8M160.6M2.32M
2026-02-276.43%10.3M160.6M2.14M
2026-02-134.85%7.8M160.2M1.94M
2026-01-304.95%7.9M160.2M2.17M
2026-01-154.99%8.0M160.2M2.11M

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call5.008.6010.600.00985.8%0.000.000.933-0.1270.003
call6.007.609.600.00835.1%0.000.000.918-0.1260.003
call7.006.608.600.00714.8%0.000.000.902-0.1230.004
call8.005.607.603.90614.2%1.000.000.883-0.1190.004
call9.004.406.600.00527.2%0.000.000.861-0.1140.005
call10.003.205.600.00449.7%0.000.000.834-0.1080.005
call11.002.154.301.20331.1%8.000.000.800-0.0990.006
call12.001.953.202.62254.8%1070.000.755-0.0890.007
call13.001.001.701.42128.3%12712.000.688-0.0730.007
call14.000.200.901.0099.4%1790.000.560-0.0530.008
call15.000.000.950.25150.1%6.000.000.435-0.0760.008
call16.000.000.450.05129.9%5780.000.293-0.0590.007
call17.000.000.750.00159.7%0.000.000.254-0.0680.007
call18.000.000.750.00185.9%0.000.000.228-0.0750.006
call19.000.000.100.00122.6%0.000.000.086-0.0240.003
call20.000.000.750.00152.9%0.000.000.076-0.0290.003
call21.000.001.150.00168.8%0.000.000.071-0.0300.003
put5.000.000.750.00741.2%0.000.00-0.067-0.1260.003
put6.000.000.750.00628.1%0.000.00-0.082-0.1250.003
put7.000.000.750.00535.5%0.000.00-0.098-0.1230.004
put8.000.000.750.00456.3%0.000.00-0.117-0.1190.004
put9.000.000.750.00386.7%0.000.00-0.139-0.1130.005
put10.000.000.750.00324.0%0.000.00-0.166-0.1060.005
put11.000.001.000.00266.1%0.000.00-0.200-0.0980.006
put12.000.001.000.10211.3%1090.00-0.245-0.0870.007
put13.000.000.750.63157.5%5.000.00-0.312-0.0720.007
put14.000.000.750.70100.9%90.000.00-0.440-0.0520.008
put15.000.401.550.70127.1%2.000.00-0.565-0.0750.008
put16.001.302.650.00178.3%0.000.00-0.707-0.0580.007
put17.002.003.600.00204.3%0.000.00-0.746-0.0660.007
put18.003.004.800.00259.8%0.000.00-0.772-0.0730.006
put19.004.005.800.00286.0%0.000.00-0.916-0.0260.003
put20.005.006.500.00266.0%0.000.00-0.924-0.0270.003
put21.005.907.400.00270.5%0.000.00-0.929-0.0280.003

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-12144Filing for proposed sale of securities under Rule 144.SEC
2026-11-12144Filing for proposed sale of securities under Rule 144.SEC
2026-11-124Statement of changes in beneficial ownership of securities2026-11-10SEC
2026-11-124Statement of changes in beneficial ownership of securities2026-11-09SEC
2026-11-128-KCurrent report2026-11-09SEC
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-10144Filing for proposed sale of securities under Rule 144.SEC
2026-11-10424B7SEC
2026-11-09144Filing for proposed sale of securities under Rule 144.SEC
2026-11-09424B7SEC
2026-11-0510-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-11-058-KCurrent report2026-11-05SEC
2026-10-168-KCurrent report2026-10-14SEC
2026-10-05SCHEDULE 13G/ASEC
2026-09-244Statement of changes in beneficial ownership of securities2026-09-22SEC
2026-09-154Statement of changes in beneficial ownership of securities2026-09-11SEC
2026-09-118-KCurrent report2026-09-09SEC
2026-09-10424B7SEC
2026-09-09424B7SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-044Statement of changes in beneficial ownership of securities2026-09-02SEC
2026-09-02144Filing for proposed sale of securities under Rule 144.SEC
2026-08-264Statement of changes in beneficial ownership of securities2026-08-24SEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-14SCHEDULE 13G/ASEC
2026-08-14144Filing for proposed sale of securities under Rule 144.SEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-13SEC
2026-08-13144Filing for proposed sale of securities under Rule 144.SEC
2026-08-134Statement of changes in beneficial ownership of securities2026-08-11SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-11002.27M3
2026-100000
2026-0900226.80M2
2026-0800151.99M6
2026-070000
2026-06009.06M1
2026-0500281.34M5
2026-0400528.16K3
2026-0300175.25M2
2026-020000
2026-010000
2025-12001.89M6
2025-1100368.05K1

Institutional holders

Manager% owned
TPG GP A, LLC28.81%
FMR LLC15.56%
BlackRock, Inc.9.37%
SUMMIT PARTNERS L P4.35%
VANGUARD PORTFOLIO MANAGEMENT LLC3.60%
JENNISON ASSOCIATES LLC3.11%
STATE STREET CORP2.59%
VANGUARD CAPITAL MANAGEMENT LLC2.51%
DIMENSIONAL FUND ADVISORS LP2.21%
GEODE CAPITAL MANAGEMENT, LLC1.82%

Funds

Fund% owned
iShares Core S&P Small-Cap ETF3.56%
VANGUARD TOTAL STOCK MARKET INDEX FUND1.74%
Fidelity Small Cap Value Fund1.68%
VIP Contrafund Portfolio1.53%
Fidelity Small Cap Growth Fund1.40%
Select Health Care Portfolio1.31%
iShares Russell 2000 ETF1.29%
VANGUARD SMALL-CAP INDEX FUND1.26%
PGIM Jennison Small Company Fund1.25%
Fidelity Value Fund1.17%

OakChart. LFST. Cached 15 minutes. Terms